Cholesterol Efflux Capacity, HDL Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin)

BACKGROUND: Recent failures of drugs that raised high-density lipoprotein (HDL) cholesterol levels to reduce cardiovascular events in clinical trials have led to increased interest in alternative indices of HDL quality, such as cholesterol efflux capacity, and HDL quantity, such as HDL particle numb...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Circulation
Auteurs principaux: Khera, Amit V., Demler, Olga V., Adelman, Steven J., Collins, Heidi L., Glynn, Robert J., Ridker, Paul M, Rader, Daniel J., Mora, Samia
Format: Artigo
Langue:Inglês
Publié: 2017
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5490983/
https://ncbi.nlm.nih.gov/pubmed/28450350
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.116.025678
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires